medtron post solid third fiscal quarter chang
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim feb
price data feb
rate updat feb
currenc amount express
methodolog valu compani
post solid fiscal third-quart perform
larg span product portfolio havent made
chang assumpt hold steadi
third-quart sale grew slightli slower
previou four quarter though firm face
unusu robust compar prior-year period
typic adopt novel product
off-set declin older product firm steadi releas
new product on-going invest pipelin
underscor confid wide econom
indic
devic softest spot quarter -- mid-
teen -- rival abbott recent receiv destin
competit product
improv data publish abbott heartmat
help attract practition attent addit
new heart transplant guidelin may lead
patient choos extracorpor membran oxygen
lvad order gain prioriti transplant
suspect guidelin chang could signific factor
reorder practition patient behavior even
abbott heart failur busi fell
fourth quarter yet clear long new usag
pattern last think could take least
year gather data outcom
large-scal clinic result
eager see
medtron tyrx antibacteri envelop cardiac rhythm
manag devic expect mid-march
smaller-scal studi hint impress reduct
infect result wrap-it trial favor
demonstr cost save avoid
complic anticip wider adopt tyrx
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
one largest medic devic compani develop
manufactur therapeut medic devic chronic diseas portfolio
spinal fixat devic neurovascular product surgic tool
compani market product healthcar institut physician
unit state oversea foreign sale account
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
product associ product pull-through tradit
in-depth discuss tyrx potenti
possibl upsid pleas see report
medtron embrac value-bas payment
final pleas see diabet franchis
closed-loop insulin pump come view
concept artifici pancrea around long
time healthcar medtron hybrid close loop
took one major step toward realiz goal type
diabet howev even requir pump user
interven releas insulin follow meal
exercis next-gen expect fiscal
would take anoth signific step toward
close loop -- act like healthi pancrea
adjust releas insulin minim input
patient mean manag insulin could
tailor individu patient theoret
would keep blood glucos healthier rang
time would minim long-term complic
diabet firm deep expertis expans data
goe creat algorithm devic along
integr medtron guardian connect continu
glucos monitor make difficult competitor
tandem becom seriou threat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end april
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end april
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
